Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Business Wire•18/11/2026•16:05 ET
1
Key Highlights
- ➤Arcus Biosciences (RCUS) will participate in two investor conferences December 1-2, 2026
- ➤Management will host an Evercore Healthcare Conference fireside chat December 1
- ➤Management will host a Citi Global Healthcare Conference fireside chat December 2
- ➤Casdatifan and quemliclustat have advanced to Phase 3 clinical trials
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and immune diseases, announced that its management team will participate in the following upcoming investor conferences in December:
Get started
Create a free account to read the full story.
